Dr. Michael Schelhaas studied chemistry at the Universities of Bonn and Karlsruhe and did post-doctoral research at the University of Pennsylvania in Philadelphia, USA. He joined Bayer AG at the Leverkusen site in 1998 and moved to LANXESS in 2004 when the company was spun off. Dr. Schelhaas held various positions in research & development, production and innovation management. He is currently focusing on innovation strategy in the Corporate Development department. As LANXESS representative at the HTGF he is enthusiastic about the combination of innovations and business ideas.